DeepMed Research

UNIVERSITY OF TENNESSEE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1794-09-10

Employees: 5K

Market Cap: -

Website: http://www.utk.edu

Clinical Trials

Radioimmunoimaging of AL Amyloidosis

Phase 1

Completed

Conditions: AL Amyloidosis

Interventions: Biological: 124I-labeled monoclonal antibody Mu 11-1F4

First Posted Date: 2011-08-04

Last Posted Date: 2012-10-11

Lead Sponsor: University of Tennessee

Target Recruit Count: 38

Registration Number: NCT01409148

Locations: 🇺🇸
University of Tennessee Medical Center, Knoxville, Tennessee, United States

Preventing Relapse Following Involuntary Smoking Abstinence

Not Applicable

Conditions: Smoking
Smoking Cessation

Interventions: Behavioral: Tobacco Use Ban
Behavioral: Tailored Pamphlet
Behavioral: Informational Pamphlet
Behavioral: Relapse Prevention Intervention

First Posted Date: 2011-06-16

Last Posted Date: 2016-11-01

Lead Sponsor: University of Tennessee

Target Recruit Count: 23000

Registration Number: NCT01374724

Locations: 🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States
🇺🇸
Wilford Hall Medical Center, Lackland AFB, Texas, United States

Physical Activity and Leisure-time Study (PALS)

Phase 1

Completed

Conditions: Physical Activity
Weight

Interventions: Behavioral: 30-min walk
Behavioral: TV commercial stepping

First Posted Date: 2011-04-27

Last Posted Date: 2012-11-09

Lead Sponsor: University of Tennessee

Target Recruit Count: 58

Registration Number: NCT01342471

Locations: 🇺🇸
HPER Building, 1914 Andy Holt Ave., Knoxville, Tennessee, United States

Savella in Treatment for Provoked Vestibulodynia

Phase 3

Completed

Conditions: Vestibulodynia
Vulvodynia

Interventions: Drug: Milnacipran

First Posted Date: 2011-02-25

Last Posted Date: 2018-06-11

Lead Sponsor: University of Tennessee

Target Recruit Count: 31

Registration Number: NCT01304589

Locations: 🇺🇸
Women's Health Specialists, PLLC, Germantown, Tennessee, United States

A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response

Not Applicable

Completed

Conditions: Vulvodynia

Interventions: Drug: Placebo oral capsule
Drug: Gabapentin

First Posted Date: 2011-02-23

Last Posted Date: 2017-11-08

Lead Sponsor: University of Tennessee

Target Recruit Count: 230

Registration Number: NCT01301001

Locations: 🇺🇸
Clinical Research Center, Memphis, Tennessee, United States
🇺🇸
Rutgers - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸
University of Rochester School of Medicine and Dentistry, Rochester, New York, United States

Trial of Steroids in Pediatric Acute Lung Injury/ARDS

Phase 2

Conditions: Acute Respiratory Distress Syndrome (ARDS)
Acute Lung Injury (ALI)

Interventions: Drug: Normal Saline (0.9%)
Drug: methylprednisolone

First Posted Date: 2011-01-11

Last Posted Date: 2014-05-28

Lead Sponsor: University of Tennessee

Target Recruit Count: 100

Registration Number: NCT01274260

Locations: 🇺🇸
Le Bonheur Children's Hospital, Memphis, Tennessee, United States

Dairy Attenuation of Metabolic Disease

Not Applicable

Completed

Conditions: Oxidative Stress
Inflammation

Interventions: Dietary Supplement: Low Dairy
Dietary Supplement: Adequate Dairy

First Posted Date: 2010-12-24

Last Posted Date: 2010-12-24

Lead Sponsor: University of Tennessee

Target Recruit Count: 40

Registration Number: NCT01266330

Locations: 🇺🇸
The University of Tennessee Nutrition and Metabolic Research Laboratory, Knoxville, Tennessee, United States

Treating Adults at Risk for Weight Gain With Interactive Technology

Phase 3

Conditions: Smoking
Body Weight

Interventions: Behavioral: Smoking Cessation
Behavioral: Smoking Cessation plus Weight Loss

First Posted Date: 2010-09-10

Last Posted Date: 2013-06-18

Lead Sponsor: University of Tennessee

Target Recruit Count: 330

Registration Number: NCT01199185

Locations: 🇺🇸
Department of Preventive Medicine, Memphis, Tennessee, United States

Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices

Not Applicable

Conditions: Contraception

Interventions: Drug: Lidocaine
Drug: Lubricant

First Posted Date: 2010-09-01

Last Posted Date: 2011-06-16

Lead Sponsor: University of Tennessee

Target Recruit Count: 210

Registration Number: NCT01192490

Locations: 🇺🇸
University of Tennessee Chattanooga Department of Obstetrics and Gynecology, Chattanooga, Tennessee, United States

Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation

Not Applicable

Conditions: Parenteral Nutrition Associated Liver Disease

Interventions: Drug: Lovaza (fish oil)

First Posted Date: 2010-07-07

Last Posted Date: 2011-06-17

Lead Sponsor: University of Tennessee

Target Recruit Count: 100

Registration Number: NCT01157780

Locations: 🇺🇸
Le Bonheur Children's Medical Center, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy